Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
{"Image DocumentName": "Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage", "Image ImageDescription": "Phase II, dose-finding study. N = 399 pts. Randomized to 3 doses of rFVIIa (40, 80, 160 \u03bcg/kg) v. placebo. Treatment given within 4 hours of ICH onset. Primary Outcome Measure: % change in ICH volume at 24 hours. Clinical Outcomes (mRS, BI, E-GOS, NIHSS) & mortality at 90 days. SA Mayer et al. \u2013 NEJM 2005:352:", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}